Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.

Abstract

BACKGROUND AND METHODS The serotonin (5-hydroxytryptamine3) antagonists have improved the treatment of acute chemotherapy-induced nausea and vomiting, but their ability to prevent delayed nausea and vomiting seems less pronounced. The results of a preliminary open trial suggested that the addition of a selective dopamine D2 antagonist could improve the… (More)

Topics

Cite this paper

@article{Herrstedt1993OndansetronPM, title={Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.}, author={J\orn Herrstedt and Tine Sigsgaard and Michael W. Boesgaard and T P Jensen and Per Dombernowsky}, journal={The New England journal of medicine}, year={1993}, volume={328 15}, pages={1076-80} }